Differential aggregation properties of alpha-synuclein isoforms
Pathologic aggregation of α-synuclein is a central process in the pathogenesis of Parkinson's disease. The α-synuclein gene (SNCA) encodes at least 4 different α-synuclein isoforms through alternative splicing (SNCA140, SNCA126, SNCA112, SNCA98). Differential expression of α-synuclein isoforms...
Saved in:
Published in | Neurobiology of aging Vol. 35; no. 8; pp. 1913 - 1919 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.08.2014
|
Subjects | |
Online Access | Get full text |
ISSN | 0197-4580 1558-1497 1558-1497 |
DOI | 10.1016/j.neurobiolaging.2014.02.009 |
Cover
Abstract | Pathologic aggregation of α-synuclein is a central process in the pathogenesis of Parkinson's disease. The α-synuclein gene (SNCA) encodes at least 4 different α-synuclein isoforms through alternative splicing (SNCA140, SNCA126, SNCA112, SNCA98). Differential expression of α-synuclein isoforms has been shown in Lewy body diseases. In contrast to the canonical α-synuclein isoform of 140 amino acid residues (SNCA140), which has been investigated in detail, little is known about the properties of the 3 alternative isoforms. We have investigated the aggregation properties of all 4 isoforms in cultured cells and analyzed fibril-formation of 3 isoforms (SNCA140, SNCA126, and SNCA98) in vitro by electron microscopy. Each of the 3 alternative isoforms aggregates significantly less than the canonical isoform SNCA140. Electron microscopy showed that SNCA140 formed the well-known relatively straight fibrils while SNCA126 formed shorter fibrils, which were arranged in parallel fibril bundles and SNCA98 formed annular structures. Expression analysis of α-synuclein isoforms in different human brain regions demonstrated low expression levels of the alternative isoforms in comparison to the canonical SNCA140 isoform. These findings demonstrate that α-synuclein isoforms differ qualitatively and quantitatively in their aggregation properties. The biological consequences of these findings remain to be explored in vitro and in vivo. |
---|---|
AbstractList | Pathologic aggregation of α-synuclein is a central process in the pathogenesis of Parkinson's disease. The α-synuclein gene (SNCA) encodes at least 4 different α-synuclein isoforms through alternative splicing (SNCA140, SNCA126, SNCA112, SNCA98). Differential expression of α-synuclein isoforms has been shown in Lewy body diseases. In contrast to the canonical α-synuclein isoform of 140 amino acid residues (SNCA140), which has been investigated in detail, little is known about the properties of the 3 alternative isoforms. We have investigated the aggregation properties of all 4 isoforms in cultured cells and analyzed fibril-formation of 3 isoforms (SNCA140, SNCA126, and SNCA98) in vitro by electron microscopy. Each of the 3 alternative isoforms aggregates significantly less than the canonical isoform SNCA140. Electron microscopy showed that SNCA140 formed the well-known relatively straight fibrils while SNCA126 formed shorter fibrils, which were arranged in parallel fibril bundles and SNCA98 formed annular structures. Expression analysis of α-synuclein isoforms in different human brain regions demonstrated low expression levels of the alternative isoforms in comparison to the canonical SNCA140 isoform. These findings demonstrate that α-synuclein isoforms differ qualitatively and quantitatively in their aggregation properties. The biological consequences of these findings remain to be explored in vitro and in vivo.Pathologic aggregation of α-synuclein is a central process in the pathogenesis of Parkinson's disease. The α-synuclein gene (SNCA) encodes at least 4 different α-synuclein isoforms through alternative splicing (SNCA140, SNCA126, SNCA112, SNCA98). Differential expression of α-synuclein isoforms has been shown in Lewy body diseases. In contrast to the canonical α-synuclein isoform of 140 amino acid residues (SNCA140), which has been investigated in detail, little is known about the properties of the 3 alternative isoforms. We have investigated the aggregation properties of all 4 isoforms in cultured cells and analyzed fibril-formation of 3 isoforms (SNCA140, SNCA126, and SNCA98) in vitro by electron microscopy. Each of the 3 alternative isoforms aggregates significantly less than the canonical isoform SNCA140. Electron microscopy showed that SNCA140 formed the well-known relatively straight fibrils while SNCA126 formed shorter fibrils, which were arranged in parallel fibril bundles and SNCA98 formed annular structures. Expression analysis of α-synuclein isoforms in different human brain regions demonstrated low expression levels of the alternative isoforms in comparison to the canonical SNCA140 isoform. These findings demonstrate that α-synuclein isoforms differ qualitatively and quantitatively in their aggregation properties. The biological consequences of these findings remain to be explored in vitro and in vivo. Pathologic aggregation of α-synuclein is a central process in the pathogenesis of Parkinson's disease. The α-synuclein gene (SNCA) encodes at least 4 different α-synuclein isoforms through alternative splicing (SNCA140, SNCA126, SNCA112, SNCA98). Differential expression of α-synuclein isoforms has been shown in Lewy body diseases. In contrast to the canonical α-synuclein isoform of 140 amino acid residues (SNCA140), which has been investigated in detail, little is known about the properties of the 3 alternative isoforms. We have investigated the aggregation properties of all 4 isoforms in cultured cells and analyzed fibril-formation of 3 isoforms (SNCA140, SNCA126, and SNCA98) in vitro by electron microscopy. Each of the 3 alternative isoforms aggregates significantly less than the canonical isoform SNCA140. Electron microscopy showed that SNCA140 formed the well-known relatively straight fibrils while SNCA126 formed shorter fibrils, which were arranged in parallel fibril bundles and SNCA98 formed annular structures. Expression analysis of α-synuclein isoforms in different human brain regions demonstrated low expression levels of the alternative isoforms in comparison to the canonical SNCA140 isoform. These findings demonstrate that α-synuclein isoforms differ qualitatively and quantitatively in their aggregation properties. The biological consequences of these findings remain to be explored in vitro and in vivo. Pathologic aggregation of alpha -synuclein is a central process in the pathogenesis of Parkinson's disease. The alpha -synuclein gene (SNCA) encodes at least 4 different alpha -synuclein isoforms through alternative splicing (SNCA140, SNCA126, SNCA112, SNCA98). Differential expression of alpha -synuclein isoforms has been shown in Lewy body diseases. In contrast to the canonical alpha -synuclein isoform of 140 amino acid residues (SNCA140), which has been investigated in detail, little is known about the properties of the 3 alternative isoforms. We have investigated the aggregation properties of all 4 isoforms in cultured cells and analyzed fibril-formation of 3 isoforms (SNCA140, SNCA126, and SNCA98) in vitro by electron microscopy. Each of the 3 alternative isoforms aggregates significantly less than the canonical isoform SNCA140. Electron microscopy showed that SNCA140 formed the well-known relatively straight fibrils while SNCA126 formed shorter fibrils, which were arranged in parallel fibril bundles and SNCA98 formed annular structures. Expression analysis of alpha -synuclein isoforms in different human brain regions demonstrated low expression levels of the alternative isoforms in comparison to the canonical SNCA140 isoform. These findings demonstrate that alpha -synuclein isoforms differ qualitatively and quantitatively in their aggregation properties. The biological consequences of these findings remain to be explored in vitro and in vivo. Abstract Pathologic aggregation of α-synuclein is a central process in the pathogenesis of Parkinson's disease. The α-synuclein gene ( SNCA ) encodes at least 4 different α-synuclein isoforms through alternative splicing ( SNCA140 , SNCA126 , SNCA112 , SNCA98 ). Differential expression of α-synuclein isoforms has been shown in Lewy body diseases. In contrast to the canonical α-synuclein isoform of 140 amino acid residues ( SNCA140 ), which has been investigated in detail, little is known about the properties of the 3 alternative isoforms. We have investigated the aggregation properties of all 4 isoforms in cultured cells and analyzed fibril-formation of 3 isoforms ( SNCA140 , SNCA126 , and SNCA98 ) in vitro by electron microscopy. Each of the 3 alternative isoforms aggregates significantly less than the canonical isoform SNCA140 . Electron microscopy showed that SNCA140 formed the well-known relatively straight fibrils while SNCA126 formed shorter fibrils, which were arranged in parallel fibril bundles and SNCA98 formed annular structures. Expression analysis of α-synuclein isoforms in different human brain regions demonstrated low expression levels of the alternative isoforms in comparison to the canonical SNCA140 isoform. These findings demonstrate that α-synuclein isoforms differ qualitatively and quantitatively in their aggregation properties. The biological consequences of these findings remain to be explored in vitro and in vivo. |
Author | Bungeroth, May Kuhlenbäumer, Gregor Appenzeller, Silke Lorenzen, Inken Pendziwiat, Manuela Regulin, Annika Grötzinger, Joachim Völker, Wolfgang |
Author_xml | – sequence: 1 givenname: May surname: Bungeroth fullname: Bungeroth, May organization: Department of Neurology, University of Kiel, Kiel, Germany – sequence: 2 givenname: Silke surname: Appenzeller fullname: Appenzeller, Silke organization: Department of Neurology, University of Kiel, Kiel, Germany – sequence: 3 givenname: Annika surname: Regulin fullname: Regulin, Annika organization: Department of Neurology, University of Kiel, Kiel, Germany – sequence: 4 givenname: Wolfgang surname: Völker fullname: Völker, Wolfgang organization: Leibniz-Institute for Atherosclerosis Research, University of Münster, Münster, Germany – sequence: 5 givenname: Inken surname: Lorenzen fullname: Lorenzen, Inken organization: Institute of Biochemistry, University of Kiel, Kiel, Germany – sequence: 6 givenname: Joachim surname: Grötzinger fullname: Grötzinger, Joachim organization: Institute of Biochemistry, University of Kiel, Kiel, Germany – sequence: 7 givenname: Manuela surname: Pendziwiat fullname: Pendziwiat, Manuela organization: Department of Neurology, University of Kiel, Kiel, Germany – sequence: 8 givenname: Gregor surname: Kuhlenbäumer fullname: Kuhlenbäumer, Gregor email: g.kuhlenbaeumer@neurologie.uni-kiel.de organization: Department of Neurology, University of Kiel, Kiel, Germany |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24629672$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkkGL1DAUx4OsuLOrX0F68OCl9SVNmhZE0V1XhQUP6jmk6WvNmEnGpBXm25s6q-CCMKd3-b0fj___XZAzHzwS8oxCRYE2L7aVxyWG3ganJ-unigHlFbAKoHtANlSItqS8k2dkA7STJRctnJOLlLYAILlsHpFzxhvWNZJtyOtrO44Y0c9Wu0JPU8RJzzb4Yh_DHuNsMRVhLLTbf9NlOvjFOLS-sCmMIe7SY_Jw1C7hk7t5Sb7evPty9aG8_fT-49Wb29KIWszlIEde9wzNwCT00nQdykaMg25qo1uoUbY9IA49g0GAYdhT2vGmaVquW8na-pI8P3rzWT8WTLPa2WTQOe0xLElRUfMWOsHFCSjjVOaEWEaf3qFLv8NB7aPd6XhQf_LJwMsjYGJIKeL4F6Gg1jrUVv1bh1rrUMBUriOvv723buz8O945autOldwcJZjz_WkxqmQseoODjWhmNQR7qujVPZFx1luj3Xc8YNqGJfrcoaIq5QX1eX2f9XsoB8ieNY3r_wtOv-MXPPLfFA |
CitedBy_id | crossref_primary_10_1111_neup_12289 crossref_primary_10_1016_j_mad_2023_111807 crossref_primary_10_20517_and_2024_15 crossref_primary_10_1007_s12035_021_02596_3 crossref_primary_10_1038_s41598_023_45078_3 crossref_primary_10_1002_cne_23901 crossref_primary_10_1007_s10048_015_0449_x crossref_primary_10_1038_s41583_023_00717_6 crossref_primary_10_3389_fnmol_2019_00189 crossref_primary_10_1016_j_arr_2019_100937 crossref_primary_10_54101_ACEN_2022_4_7 crossref_primary_10_1134_S1819712421040073 crossref_primary_10_1111_jnc_13392 crossref_primary_10_1021_acschemneuro_8b00140 crossref_primary_10_1074_jbc_REV120_011743 crossref_primary_10_1016_j_drugalcdep_2015_05_045 crossref_primary_10_1021_acs_jpcb_2c03676 crossref_primary_10_1016_j_nbd_2023_106337 crossref_primary_10_1002_mgg3_407 crossref_primary_10_1016_j_exger_2018_12_008 crossref_primary_10_3390_molecules27061776 crossref_primary_10_3390_biom11081067 crossref_primary_10_3390_biology12020155 crossref_primary_10_1007_s00702_019_02025_9 crossref_primary_10_1016_j_biochi_2020_10_019 crossref_primary_10_23868_201707012 crossref_primary_10_3390_biom5032073 crossref_primary_10_1186_s40478_014_0176_9 crossref_primary_10_3390_genes9020063 crossref_primary_10_1073_pnas_2313465121 |
Cites_doi | 10.1111/j.1365-2990.2004.00572.x 10.1021/bi027363r 10.1016/S0002-9440(10)64781-5 10.1074/jbc.M107045200 10.1016/S0140-6736(04)17103-1 10.1007/s10048-007-0106-0 10.1111/j.1471-4159.2007.04764.x 10.1523/JNEUROSCI.2617-07.2007 10.1126/science.1090278 10.1016/S0022-2836(02)00735-0 10.1097/01.wnr.0000224773.66904.e7 10.1073/pnas.0400553101 10.1007/s10048-008-0124-6 10.1126/science.276.5321.2045 10.1111/j.1742-4658.2007.05733.x 10.1038/ng.487 10.1007/s00109-003-0464-5 10.1212/01.wnl.0000271080.53272.c7 10.1038/ncb748 10.1038/42166 10.1111/j.1471-4159.2008.05407.x 10.1074/jbc.M411805200 |
ContentType | Journal Article |
Copyright | 2014 Elsevier Inc. Elsevier Inc. Copyright © 2014 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2014 Elsevier Inc. – notice: Elsevier Inc. – notice: Copyright © 2014 Elsevier Inc. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7TK |
DOI | 10.1016/j.neurobiolaging.2014.02.009 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Neurosciences Abstracts |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Neurosciences Abstracts |
DatabaseTitleList | MEDLINE - Academic MEDLINE Neurosciences Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1558-1497 |
EndPage | 1919 |
ExternalDocumentID | 24629672 10_1016_j_neurobiolaging_2014_02_009 S0197458014002012 1_s2_0_S0197458014002012 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M -~X .1- .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29N 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM 9JO AABNK AADFP AAEDT AAEDW AAGJA AAGUQ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXLA AAXUO AAYWO ABBQC ABCQJ ABFNM ABFRF ABGSF ABIVO ABJNI ABLJU ABMAC ABMZM ABOYX ABUDA ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACIUM ACRLP ACRPL ACVFH ACXNI ADBBV ADCNI ADEZE ADMUD ADNMO ADUVX AEBSH AEFWE AEHWI AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGRDE AGUBO AGWIK AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRLJ AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDW HMK HMO HMQ HVGLF HZ~ IHE J1W KOM LX8 M29 M2V M41 MO0 MOBAO MVM N9A O-L O9- OAUVE OD~ OKEIE OO0 OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SNS SPCBC SSB SSH SSN SSU SSY SSZ T5K WUQ Z5R ZGI ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG AADPK AAIAV ABLVK ABYKQ AFYLN AJBFU DOVZS EFLBG LCYCR AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 ACLOT ~HD 7TK |
ID | FETCH-LOGICAL-c535t-d7f43b2ecd270b7c99e765fda63ca803e78b0eedb20d50c2eb119466684a87283 |
IEDL.DBID | .~1 |
ISSN | 0197-4580 1558-1497 |
IngestDate | Sun Sep 28 11:32:42 EDT 2025 Sun Sep 28 01:29:29 EDT 2025 Mon Jul 21 06:07:25 EDT 2025 Tue Jul 01 01:28:10 EDT 2025 Thu Apr 24 23:06:09 EDT 2025 Fri Feb 23 02:27:29 EST 2024 Sun Feb 23 10:19:35 EST 2025 Tue Aug 26 19:57:19 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | Aggregation Parkinson Alpha-synuclein Isoforms |
Language | English |
License | Copyright © 2014 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c535t-d7f43b2ecd270b7c99e765fda63ca803e78b0eedb20d50c2eb119466684a87283 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
PMID | 24629672 |
PQID | 1524174972 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_1534809545 proquest_miscellaneous_1524174972 pubmed_primary_24629672 crossref_primary_10_1016_j_neurobiolaging_2014_02_009 crossref_citationtrail_10_1016_j_neurobiolaging_2014_02_009 elsevier_sciencedirect_doi_10_1016_j_neurobiolaging_2014_02_009 elsevier_clinicalkeyesjournals_1_s2_0_S0197458014002012 elsevier_clinicalkey_doi_10_1016_j_neurobiolaging_2014_02_009 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-08-01 |
PublicationDateYYYYMMDD | 2014-08-01 |
PublicationDate_xml | – month: 08 year: 2014 text: 2014-08-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Neurobiology of aging |
PublicationTitleAlternate | Neurobiol Aging |
PublicationYear | 2014 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Danzer, Haasen, Karow, Moussaud, Habeck, Giese, Kretzschmar, Hengerer, Kostka (bib7) 2007; 27 Singleton, Farrer, Johnson, Singleton, Hague, Kachergus, Hulihan, Peuralinna, Dutra, Nussbaum, Lincoln, Crawley, Hanson, Maraganore, Adler, Cookson, Muenter, Baptista, Miller, Blancato, Hardy, Gwinn-Hardy (bib17) 2003; 302 Beyer, Lao, Carrato, Mate, Lopez, Ferrer, Ariza (bib5) 2004; 30 Beyer, Humbert, Ferrer, Lao, Carrato, Lopez, Ferrer, Ariza (bib4) 2006; 17 Simon-Sanchez, Schulte, Bras, Sharma, Gibbs, Berg, Paisan-Ruiz, Lichtner, Scholz, Hernandez, Kruger, Federoff, Klein, Goate, Perlmutter, Bonin, Nalls, Illig, Gieger, Houlden, Steffens, Okun, Racette, Cookson, Foote, Fernandez, Traynor, Schreiber, Arepalli, Zonozi, Gwinn, van der Brug, Lopez, Chanock, Schatzkin, Park, Hollenbeck, Gao, Huang, Wood, Lorenz, Deuschl, Chen, Riess, Hardy, Singleton, Gasser (bib16) 2009; 41 Beyer, Domingo-Sabat, Lao, Carrato, Ferrer, Ariza (bib3) 2008; 9 Fujiwara, Hasegawa, Dohmae, Kawashima, Masliah, Goldberg, Shen, Takio, Iwatsubo (bib9) 2002; 4 Lashuel, Petre, Wall, Simon, Nowak, Walz, Lansbury (bib11) 2002; 322 Murray, Giasson, Quinn, Koppaka, Axelsen, Ischiropoulos, Trojanowski, Lee (bib13) 2003; 42 Beyer, Domingo-Sabat, Humbert, Carrato, Ferrer, Ariza (bib2) 2008; 9 Duda, Giasson, Chen, Gur, Hurtig, Stern, Gollomp, Ischiropoulos, Lee, Trojanowski (bib8) 2000; 157 Ulmer, Bax, Cole, Nussbaum (bib21) 2005; 280 Ahn, Kim, Kim, Park, Lee, Min, Kim, Kim, Kim, Kim, Cho, Jeon (bib1) 2008; 70 Chartier-Harlin, Kachergus, Roumier, Mouroux, Douay, Lincoln, Levecque, Larvor, Andrieux, Hulihan, Waucquier, Defebvre, Amouyel, Farrer, Destee (bib6) 2004; 364 Spillantini, Schmidt, Lee, Trojanowski, Jakes, Goedert (bib18) 1997; 388 Lee, Choi, Lee (bib12) 2002; 277 Opazo, Krenz, Heermann, Schulz, Falkenburger (bib14) 2008; 106 Jao, Der-Sarkissian, Chen, Langen (bib10) 2004; 101 Polymeropoulos, Lavedan, Leroy, Ide, Dehejia, Dutra, Pike, Root, Rubenstein, Boyer, Stenroos, Chandrasekharappa, Athanassiadou, Papapetropoulos, Johnson, Lazzarini, Duvoisin, Di Iorio, Golbe, Nussbaum (bib15) 1997; 276 Uversky (bib22) 2007; 103 Stefani, Dobson (bib19) 2003; 81 Tsigelny, Bar-On, Sharikov, Crews, Hashimoto, Miller, Keller, Platoshyn, Yuan, Masliah (bib20) 2007; 274 Opazo (10.1016/j.neurobiolaging.2014.02.009_bib14) 2008; 106 Polymeropoulos (10.1016/j.neurobiolaging.2014.02.009_bib15) 1997; 276 Singleton (10.1016/j.neurobiolaging.2014.02.009_bib17) 2003; 302 Beyer (10.1016/j.neurobiolaging.2014.02.009_bib5) 2004; 30 Murray (10.1016/j.neurobiolaging.2014.02.009_bib13) 2003; 42 Ulmer (10.1016/j.neurobiolaging.2014.02.009_bib21) 2005; 280 Chartier-Harlin (10.1016/j.neurobiolaging.2014.02.009_bib6) 2004; 364 Duda (10.1016/j.neurobiolaging.2014.02.009_bib8) 2000; 157 Lashuel (10.1016/j.neurobiolaging.2014.02.009_bib11) 2002; 322 Simon-Sanchez (10.1016/j.neurobiolaging.2014.02.009_bib16) 2009; 41 Jao (10.1016/j.neurobiolaging.2014.02.009_bib10) 2004; 101 Stefani (10.1016/j.neurobiolaging.2014.02.009_bib19) 2003; 81 Beyer (10.1016/j.neurobiolaging.2014.02.009_bib4) 2006; 17 Fujiwara (10.1016/j.neurobiolaging.2014.02.009_bib9) 2002; 4 Tsigelny (10.1016/j.neurobiolaging.2014.02.009_bib20) 2007; 274 Beyer (10.1016/j.neurobiolaging.2014.02.009_bib2) 2008; 9 Ahn (10.1016/j.neurobiolaging.2014.02.009_bib1) 2008; 70 Lee (10.1016/j.neurobiolaging.2014.02.009_bib12) 2002; 277 Spillantini (10.1016/j.neurobiolaging.2014.02.009_bib18) 1997; 388 Danzer (10.1016/j.neurobiolaging.2014.02.009_bib7) 2007; 27 Beyer (10.1016/j.neurobiolaging.2014.02.009_bib3) 2008; 9 Uversky (10.1016/j.neurobiolaging.2014.02.009_bib22) 2007; 103 |
References_xml | – volume: 70 start-page: 43 year: 2008 end-page: 49 ident: bib1 article-title: alpha-Synuclein gene duplication is present in sporadic Parkinson disease publication-title: Neurology – volume: 9 start-page: 15 year: 2008 end-page: 23 ident: bib3 article-title: Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases publication-title: Neurogenetics – volume: 103 start-page: 17 year: 2007 end-page: 37 ident: bib22 article-title: Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation publication-title: J. Neurochem. – volume: 302 start-page: 841 year: 2003 ident: bib17 article-title: alpha-Synuclein locus triplication causes Parkinson's disease publication-title: Science – volume: 27 start-page: 9220 year: 2007 end-page: 9232 ident: bib7 article-title: Different species of alpha-synuclein oligomers induce calcium influx and seeding publication-title: J. Neurosci. – volume: 322 start-page: 1089 year: 2002 end-page: 1102 ident: bib11 article-title: Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils publication-title: J. Mol. Biol. – volume: 4 start-page: 160 year: 2002 end-page: 164 ident: bib9 article-title: alpha-Synuclein is phosphorylated in synucleinopathy lesions publication-title: Nat. Cell Biol. – volume: 101 start-page: 8331 year: 2004 end-page: 8336 ident: bib10 article-title: Structure of membrane-bound alpha-synuclein studied by site-directed spin labeling publication-title: Proc. Natl. Acad. Sci. U.S.A – volume: 41 start-page: 1308 year: 2009 end-page: 1312 ident: bib16 article-title: Genome-wide association study reveals genetic risk underlying Parkinson's disease publication-title: Nat. Genet. – volume: 364 start-page: 1167 year: 2004 end-page: 1169 ident: bib6 article-title: Alpha-synuclein locus duplication as a cause of familial Parkinson's disease publication-title: Lancet – volume: 277 start-page: 671 year: 2002 end-page: 678 ident: bib12 article-title: Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form publication-title: J. Biol. Chem. – volume: 42 start-page: 8530 year: 2003 end-page: 8540 ident: bib13 article-title: Role of alpha-synuclein carboxy-terminus on fibril formation in vitro publication-title: Biochemistry – volume: 81 start-page: 678 year: 2003 end-page: 699 ident: bib19 article-title: Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution publication-title: J. Mol. Med. – volume: 280 start-page: 9595 year: 2005 end-page: 9603 ident: bib21 article-title: Structure and dynamics of micelle-bound human alpha-synuclein publication-title: J. Biol. Chem. – volume: 157 start-page: 1439 year: 2000 end-page: 1445 ident: bib8 article-title: Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies publication-title: Am. J. Pathol. – volume: 388 start-page: 839 year: 1997 end-page: 840 ident: bib18 article-title: Alpha-synuclein in Lewy bodies publication-title: Nature – volume: 17 start-page: 1327 year: 2006 end-page: 1330 ident: bib4 article-title: Low alpha-synuclein 126 mRNA levels in dementia with Lewy bodies and Alzheimer disease publication-title: Neuroreport – volume: 106 start-page: 529 year: 2008 end-page: 540 ident: bib14 article-title: Accumulation and clearance of alpha-synuclein aggregates demonstrated by time-lapse imaging publication-title: J. Neurochem. – volume: 30 start-page: 601 year: 2004 end-page: 607 ident: bib5 article-title: Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies publication-title: Neuropathol. Appl. Neurobiol. – volume: 276 start-page: 2045 year: 1997 end-page: 2047 ident: bib15 article-title: Mutation in the alpha-synuclein gene identified in families with Parkinson's disease publication-title: Science – volume: 274 start-page: 1862 year: 2007 end-page: 1877 ident: bib20 article-title: Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synuclein publication-title: FEBS J. – volume: 9 start-page: 163 year: 2008 end-page: 172 ident: bib2 article-title: Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease publication-title: Neurogenetics – volume: 30 start-page: 601 year: 2004 ident: 10.1016/j.neurobiolaging.2014.02.009_bib5 article-title: Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies publication-title: Neuropathol. Appl. Neurobiol. doi: 10.1111/j.1365-2990.2004.00572.x – volume: 42 start-page: 8530 year: 2003 ident: 10.1016/j.neurobiolaging.2014.02.009_bib13 article-title: Role of alpha-synuclein carboxy-terminus on fibril formation in vitro publication-title: Biochemistry doi: 10.1021/bi027363r – volume: 157 start-page: 1439 year: 2000 ident: 10.1016/j.neurobiolaging.2014.02.009_bib8 article-title: Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies publication-title: Am. J. Pathol. doi: 10.1016/S0002-9440(10)64781-5 – volume: 277 start-page: 671 year: 2002 ident: 10.1016/j.neurobiolaging.2014.02.009_bib12 article-title: Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form publication-title: J. Biol. Chem. doi: 10.1074/jbc.M107045200 – volume: 364 start-page: 1167 year: 2004 ident: 10.1016/j.neurobiolaging.2014.02.009_bib6 article-title: Alpha-synuclein locus duplication as a cause of familial Parkinson's disease publication-title: Lancet doi: 10.1016/S0140-6736(04)17103-1 – volume: 9 start-page: 15 year: 2008 ident: 10.1016/j.neurobiolaging.2014.02.009_bib3 article-title: Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases publication-title: Neurogenetics doi: 10.1007/s10048-007-0106-0 – volume: 103 start-page: 17 year: 2007 ident: 10.1016/j.neurobiolaging.2014.02.009_bib22 article-title: Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation publication-title: J. Neurochem. doi: 10.1111/j.1471-4159.2007.04764.x – volume: 27 start-page: 9220 year: 2007 ident: 10.1016/j.neurobiolaging.2014.02.009_bib7 article-title: Different species of alpha-synuclein oligomers induce calcium influx and seeding publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.2617-07.2007 – volume: 302 start-page: 841 year: 2003 ident: 10.1016/j.neurobiolaging.2014.02.009_bib17 article-title: alpha-Synuclein locus triplication causes Parkinson's disease publication-title: Science doi: 10.1126/science.1090278 – volume: 322 start-page: 1089 year: 2002 ident: 10.1016/j.neurobiolaging.2014.02.009_bib11 article-title: Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils publication-title: J. Mol. Biol. doi: 10.1016/S0022-2836(02)00735-0 – volume: 17 start-page: 1327 year: 2006 ident: 10.1016/j.neurobiolaging.2014.02.009_bib4 article-title: Low alpha-synuclein 126 mRNA levels in dementia with Lewy bodies and Alzheimer disease publication-title: Neuroreport doi: 10.1097/01.wnr.0000224773.66904.e7 – volume: 101 start-page: 8331 year: 2004 ident: 10.1016/j.neurobiolaging.2014.02.009_bib10 article-title: Structure of membrane-bound alpha-synuclein studied by site-directed spin labeling publication-title: Proc. Natl. Acad. Sci. U.S.A doi: 10.1073/pnas.0400553101 – volume: 9 start-page: 163 year: 2008 ident: 10.1016/j.neurobiolaging.2014.02.009_bib2 article-title: Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease publication-title: Neurogenetics doi: 10.1007/s10048-008-0124-6 – volume: 276 start-page: 2045 year: 1997 ident: 10.1016/j.neurobiolaging.2014.02.009_bib15 article-title: Mutation in the alpha-synuclein gene identified in families with Parkinson's disease publication-title: Science doi: 10.1126/science.276.5321.2045 – volume: 274 start-page: 1862 year: 2007 ident: 10.1016/j.neurobiolaging.2014.02.009_bib20 article-title: Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synuclein publication-title: FEBS J. doi: 10.1111/j.1742-4658.2007.05733.x – volume: 41 start-page: 1308 year: 2009 ident: 10.1016/j.neurobiolaging.2014.02.009_bib16 article-title: Genome-wide association study reveals genetic risk underlying Parkinson's disease publication-title: Nat. Genet. doi: 10.1038/ng.487 – volume: 81 start-page: 678 year: 2003 ident: 10.1016/j.neurobiolaging.2014.02.009_bib19 article-title: Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution publication-title: J. Mol. Med. doi: 10.1007/s00109-003-0464-5 – volume: 70 start-page: 43 year: 2008 ident: 10.1016/j.neurobiolaging.2014.02.009_bib1 article-title: alpha-Synuclein gene duplication is present in sporadic Parkinson disease publication-title: Neurology doi: 10.1212/01.wnl.0000271080.53272.c7 – volume: 4 start-page: 160 year: 2002 ident: 10.1016/j.neurobiolaging.2014.02.009_bib9 article-title: alpha-Synuclein is phosphorylated in synucleinopathy lesions publication-title: Nat. Cell Biol. doi: 10.1038/ncb748 – volume: 388 start-page: 839 year: 1997 ident: 10.1016/j.neurobiolaging.2014.02.009_bib18 article-title: Alpha-synuclein in Lewy bodies publication-title: Nature doi: 10.1038/42166 – volume: 106 start-page: 529 year: 2008 ident: 10.1016/j.neurobiolaging.2014.02.009_bib14 article-title: Accumulation and clearance of alpha-synuclein aggregates demonstrated by time-lapse imaging publication-title: J. Neurochem. doi: 10.1111/j.1471-4159.2008.05407.x – volume: 280 start-page: 9595 year: 2005 ident: 10.1016/j.neurobiolaging.2014.02.009_bib21 article-title: Structure and dynamics of micelle-bound human alpha-synuclein publication-title: J. Biol. Chem. doi: 10.1074/jbc.M411805200 |
SSID | ssj0007476 |
Score | 2.2803779 |
Snippet | Pathologic aggregation of α-synuclein is a central process in the pathogenesis of Parkinson's disease. The α-synuclein gene (SNCA) encodes at least 4 different... Abstract Pathologic aggregation of α-synuclein is a central process in the pathogenesis of Parkinson's disease. The α-synuclein gene ( SNCA ) encodes at least... Pathologic aggregation of alpha -synuclein is a central process in the pathogenesis of Parkinson's disease. The alpha -synuclein gene (SNCA) encodes at least 4... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1913 |
SubjectTerms | Aggregation Alpha-synuclein alpha-Synuclein - chemistry alpha-Synuclein - metabolism Amino Acid Sequence Brain - metabolism HEK293 Cells Humans Internal Medicine Isoforms Molecular Sequence Data Neurology Parkinson Parkinson Disease - genetics Protein Aggregates Protein Aggregation, Pathological - metabolism Protein Isoforms - metabolism |
Title | Differential aggregation properties of alpha-synuclein isoforms |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0197458014002012 https://www.clinicalkey.es/playcontent/1-s2.0-S0197458014002012 https://dx.doi.org/10.1016/j.neurobiolaging.2014.02.009 https://www.ncbi.nlm.nih.gov/pubmed/24629672 https://www.proquest.com/docview/1524174972 https://www.proquest.com/docview/1534809545 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9RAEB9KBfFF1PpxWssKxbd4281-hSLlqC2nYl-00Ldld7NbrtTc0Vwf-uLf7uwmuVK0peJjlgwJs_Px22TmNwDbmPQtk1YW2lpfcBF94aKLheY1jw4PLNqmBudvR3J6zL-ciJM12B96YVJZZR_7u5ieo3W_Mu61OV7MZuPvCE4UF4n9JGGePGmYc5Vs_cOv6zIPhMuya5lO_N6aPoTt6xqvzBmZ2I7yRKBU6MU7Bs_qtjR1GwzN6ejwCTzucSSZdK_6FNZC8ww2Jg2eoX9ekfckV3bmT-YbsPepn4KC3nxO7CkesU_zhpBF-hR_kThVyTyS3HdbtFdN4jieNWTWzhOkbZ_D8eHBj_1p0Q9OKLwoxbKoVeSlY8HXTFGnfFUFJUWsrSy91bQMSjuKydExWgvqGcbrncQzLzW3WiHgeAHrzbwJr4BYBBBC0RhoWfHoZeWicmWQuKTwaBhGsDvoyfieVTwNtzg3Q_nYmbmpZZO0bCgzqOURiJX0omPXuKfcx2FLzNBBijHPYBq4p7z6m3xoewduzY5p8U7zh5GNYG8lecNO_-HZ7wYbMujK6f-MbcL8Ep8pEE4pXil21z0l1wiLuRjBy84AV5pjXLJKKvb6v9_xDTxKV12h4yasLy8uw1sEX0u3lb1rCx5MPn-dHv0GsvUywA |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaqIgEXBJTHtjyMVHEL6zp-RQhVVaFaoO2FVurNsh27WlSyq2Z76IXfzoyTbFVBURFXJ6NE43l8Tma-IWQTkr7jyqnCOBcKIVMofPKpMKIWycOBxThscD44VJNj8eVEnqyQ3aEXBssq-9jfxfQcrfuVca_N8Xw6HX8DcKKFRPYTxDw4afiOwDEHYNTvfl7VeQBeVl3PNBJ8G3aXbF4VeWXSSKQ7yiOBsNJLdBSe1U156iYcmvPR3kPyoAeSdKd710dkJTaPydpOA4foH5f0Lc2lnfmb-RrZ_tiPQQF3PqPuFM7Yp3lH6By_xZ8jqSqdJZobb4v2skGS42lDp-0MMW37hBzvfTranRT95IQiyFIuilonUXoeQ8018zpUVdRKptqpMjjDyqiNZ5AdPWe1ZIFDwN5ConllhDMaEMdTstrMmvicUAcIQmqWIisrkYKqfNK-jAqWNJwN44i8H_RkQ08rjtMtzuxQP_bdXteyRS1bxi1oeUTkUnre0WvcUu7DsCV2aCGFoGchD9xSXv9JPra9B7d2y7Zwp_3NykZkeyl5zVD_4dlvBhuy4Mv4g8Y1cXYBz5SAp7SoNP_bPaUwgIuFHJFnnQEuNceF4pXSfP2_3_E1uTc5Oti3-58Pv26Q-3ilq3p8QVYX5xfxJSCxhX-VPe0XUvA0SQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differential+aggregation+properties+of+alpha-synuclein+isoforms&rft.jtitle=Neurobiology+of+aging&rft.au=Bungeroth%2C+May&rft.au=Appenzeller%2C+Silke&rft.au=Regulin%2C+Annika&rft.au=V%C3%B6lker%2C+Wolfgang&rft.date=2014-08-01&rft.eissn=1558-1497&rft.volume=35&rft.issue=8&rft.spage=1913&rft_id=info:doi/10.1016%2Fj.neurobiolaging.2014.02.009&rft_id=info%3Apmid%2F24629672&rft.externalDocID=24629672 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01974580%2FS0197458014X00059%2Fcov150h.gif |